Nimorazole

Nimorazole
	File:Nimorazol.svg
Systematic (IUPAC) name
	4-[2-(5-nitro-1H-imidazol-1-yl)ethyl]morpholine
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
CAS Number	6506-37-2
ATC code	P01AB06 (WHO) QP51AA06 (WHO)
PubChem	CID: 23009
ChemSpider	21533
UNII	469ULX0H4G
KEGG	D07352
Chemical data
Formula	C9H14N4O3
Molecular mass	226.23 g/mol
	SMILES C1COCCN1CCN2C=NC=C2[N+](=O)[O-] ;
	InChI InChI=1S/C9H14N4O3/c14-13(15)9-7-10-8-12(9)2-1-11-3-5-16-6-4-11/h7-8H,1-6H2 ; Key:MDJFHRLTPRPZLY-UHFFFAOYSA-N ;
(verify)

Nimorazole (INN) is a nitroimidazole anti-infective.^[1] It is also being investigated for the treatment of head and neck cancer.^[2]^[3]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

↑ Lua error in package.lua at line 80: module 'strict' not found.
↑ Lua error in package.lua at line 80: module 'strict' not found.
↑ Clinical trial number NCT01507467 for "IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck" at ClinicalTrials.gov